News/ News/ Oncology Sanofi makes another pipeline deal, tapping Adagene for antibody tech Phil Taylor Adagene, immuno-oncology, Oncology, partnering, Sanofi 0 Comment Sanofi’s rash of dealmaking has continued with a $2.5 billion tie-up with Chinese cancer immunotherapy biotech Adagene, focused Share X Sanofi makes another pipeline deal, tapping Adagene for antibody tech https://pharmaphorum.com/news/sanofi-makes-another-pipeline-deal-tapping-adagene-for-antibody-tech/
News/ News/ News/ Oncology/ R&D China’s Adagene raises $69m for cancer immunotherapies Phil Taylor Adagene, antibody, China, financing, immuno-oncology, Oncology 0 Comment Chinese biotech Adagene has raised $69 million in fourth-round financing to help usher its immuno-oncology drugs – including Share X China’s Adagene raises $69m for cancer immunotherapies https://pharmaphorum.com/news/chinas-adagene-raises-69m-for-cancer-immunotherapies/
Adagene, immuno-oncology, Oncology, partnering, Sanofi
0 Comment
